Overview

Flupenthixol and Haloperidol for Treating Cocaine Abuse Schizophrenics - 9

Status:
Completed
Trial end date:
1999-05-01
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study is to evaluate the safety and efficacy of flupenthixol and haloperidol for cocaine dependence in individuals with schizophrenia/schizoaffective illness.
Phase:
Phase 2
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
National Institute on Drug Abuse (NIDA)
Collaborator:
New York State Psychiatric Institute
Treatments:
Cocaine
Flupenthixol
Flupenthixol decanoate
Haloperidol
Haloperidol decanoate
Criteria
Please contact site for information.